Cost-Effectiveness of Mechanical Thrombectomy for Acute Ischemic Stroke: Colombian Health System Perspective

Author(s)

Giraldo Caicedo A1, Ruiz ÁJ2, Holguín D JI3, Escobar Rojas W4, Rosselli D5
1Pontificia Universidad Javeriana, Cali, Colombia, 2Pontificia Universidad Javeriana, Bogota, Colombia, 3DIME Clinica Neurocardiovascular, Cali, Colombia, 4Clínica Imbanaco, Cali, Colombia, 5Pontificia Universidad Javeriana, Bogota, CUN, Colombia

Presentation Documents

OBJECTIVES: Mechanical thrombectomy plus intravenous thrombolysis is the treatment of choice for patients with ischemic stroke due in large vessels of the anterior circulation. The number of patients with mechanical thrombectomy has increased. Our objective was to establish if it is cost-effective for the Colombian Health System.

METHODS: We conducted a systematic review of the literature with meta-analysis, limited to randomized controlled trials comparing the efficacy and safety of second-generation mechanical thrombectomy devices for the treatment of patients with ischemic stroke of the large vessels of the anterior circulation. Only direct medical costs were estimated, utilities were derived from the literature. Annual discount rate was 5%. With clinical data extracted from the meta-analysis, we developed a decision tree and a Markov model, with a time horizon of 5 years and the perspective of the Colombian healthcare system, calculated incremental cost-utility ratios, and performed deterministic and probabilistic sensitivity analysis.

RESULTS: Mechanical thrombectomy plus intravenous thrombolysis is more effective than intravenous thrombolysis alone for functional independence, RR 1.59, (95% CI: 1.41-1.78). No difference in mortality RR 0.86 (95% CI: 0.71-1.04) or symptomatic intracranial hemorrhage RR 1.16 (95% CI: 0.76-1.78). In the base case, mechanical thrombectomy plus intravenous thrombolysis has an incremental cost of COP $9,697,228 (USD $2,591) and an incremental utility of 0.453 QALYs. Incremental cost-utility ratio of COP $21,403,843 (USD $5,718). The probabilistic sensitivity analysis, 64 % of the simulations are below thewillingness to pay threshold of COP $22,949,633 (USD $6,131).

CONCLUSIONS: Mechanical thrombectomy plus intravenous thrombolysis provides more functional independence, but no difference in symptomatic intracranial hemorrhage or mortality, and is a cost-effective alternative compared to intravenous thrombolysis alone, for the treatment of anterior circulation large vessel ischemic stroke in the Colombian context.

Conference/Value in Health Info

2023-05, ISPOR 2023, Boston, MA, USA

Value in Health, Volume 26, Issue 6, S2 (June 2023)

Code

EE107

Topic

Economic Evaluation

Topic Subcategory

Cost-comparison, Effectiveness, Utility, Benefit Analysis

Disease

Cardiovascular Disorders (including MI, Stroke, Circulatory), Medical Devices

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×